Forward Citations = 1

Loading Chart...

7 inventors (with patents filed for the assignee):

Xiao Huang (6 out of 6 patents)

Xiaoqiang Kang (6 out of 7 patents)

Shoupeng Lai (4 out of 4 patents)

4. Lijun Zhou (1 out of 1 patent)

5. Jianming Sun (1 out of 2 patents)

6. Yujia Dang (1 out of 1 patent)

7. Huan Lin (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 11912777 - Antibodies binding TNFR2 and uses thereof (2024-02-27),

2. 11807683 - Antibody binding TIM-3 and use thereof (2023-11-07),

3. 11802145 - Recombinant protein targeting PD-1 and TGFß (2023-10-31),

4. 11466086 - Antibodies binding 4-1BB and uses thereof (2022-10-11),

5. 11136394 - Antibody binding PD-1 and use thereof (2021-10-05),

6. 10844121 - Antibodies binding LAG-3 and uses thereof (2020-11-24),

Nanjing Leads Biolabs Co., Ltd. is a leading biotechnology company specializing in the research, development, and production of innovative solutions for life science research. With a focus on precision medicine and genetic testing, the company delivers high-quality products and services to meet the needs of researchers and healthcare professionals worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

6 Patents

#57 in Nanjing

#3,927 in China

Nanjing, China

Nanjing Leads Biolabs Co., Ltd.